These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 24798552)

  • 1. Defining dysbiosis and its influence on host immunity and disease.
    Petersen C; Round JL
    Cell Microbiol; 2014 Jul; 16(7):1024-33. PubMed ID: 24798552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Richness and diversity of mammalian fungal communities shape innate and adaptive immunity in health and disease.
    Rizzetto L; De Filippo C; Cavalieri D
    Eur J Immunol; 2014 Nov; 44(11):3166-81. PubMed ID: 25257052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch's postulates.
    Zhao H; Zhang W; Cheng D; You L; Huang Y; Lu Y
    Front Med (Lausanne); 2022; 9():1023896. PubMed ID: 36438062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of microbiota and innate immunity in recurrent Clostridium difficile infection.
    Bibbò S; Lopetuso LR; Ianiro G; Di Rienzo T; Gasbarrini A; Cammarota G
    J Immunol Res; 2014; 2014():462740. PubMed ID: 24995345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-promoting effects of microbial dysbiosis.
    Sheflin AM; Whitney AK; Weir TL
    Curr Oncol Rep; 2014 Oct; 16(10):406. PubMed ID: 25123079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
    Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
    Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.
    Calvo-Barreiro L; Eixarch H; Montalban X; Espejo C
    Autoimmun Rev; 2018 Feb; 17(2):165-174. PubMed ID: 29191793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota-Nourishing Immunity: A Guide to Understanding Our Microbial Self.
    Litvak Y; Bäumler AJ
    Immunity; 2019 Aug; 51(2):214-224. PubMed ID: 31433969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human microbiome: opportunities and challenges for clinical care.
    Rogers GB
    Intern Med J; 2015 Sep; 45(9):889-98. PubMed ID: 25443179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drosophila as a model for intestinal dysbiosis and chronic inflammatory diseases.
    Lee KA; Lee WJ
    Dev Comp Immunol; 2014 Jan; 42(1):102-10. PubMed ID: 23685204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
    Lin L; Zhang J
    BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses to Clostridium difficile infection.
    Madan R; Petri WA
    Trends Mol Med; 2012 Nov; 18(11):658-66. PubMed ID: 23084763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-microbiota interplay in mediating immune disorders.
    Felix KM; Tahsin S; Wu HJ
    Ann N Y Acad Sci; 2018 Apr; 1417(1):57-70. PubMed ID: 28984367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
    Raftery AL; Tsantikos E; Harris NL; Hibbs ML
    Front Immunol; 2020; 11():2144. PubMed ID: 33042125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
    Peterson CT; Sharma V; Elmén L; Peterson SN
    Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From stool transplants to next-generation microbiota therapeutics.
    Petrof EO; Khoruts A
    Gastroenterology; 2014 May; 146(6):1573-1582. PubMed ID: 24412527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T lymphocytes in the intestinal mucosa: defense and tolerance.
    Ma H; Tao W; Zhu S
    Cell Mol Immunol; 2019 Mar; 16(3):216-224. PubMed ID: 30787416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.